PAP
PYXS icon

Persistent Asset Partners’s Pyxis Oncology PYXS Stock Holding History

Persistent Asset Partners’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.5K Buy
+990
New +$1.89K 0.01% 465

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Persistent Asset Partners's PYXS Position: Q4 2025 in Review

Persistent Asset Partners sold out of Pyxis Oncology (PYXS) in Q4 2025, closing a stake of 34,632 shares — an estimated $76.9K sold.

Persistent Asset Partners first reported a position in PYXS in Q3 2025 and held it in 1 quarter. The position peaked at $76.9K in Q3 2025. 79 funds tracked by Wall St. Rank hold PYXS as of Q4 2025.

  • Persistent Asset Partners reported no remaining Pyxis Oncology position as of Q4 2025 after selling out during the quarter.
  • Persistent Asset Partners sold 34,632 Pyxis Oncology shares in Q4 2025, an estimated $76.9K.
  • Persistent Asset Partners first reported a position in Pyxis Oncology in Q3 2025 and held it in 1 quarter.
  • Persistent Asset Partners's Pyxis Oncology position peaked at $76.9K in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Pyxis Oncology as of Q4 2025.

Based on Persistent Asset Partners's 13F filing for Q4 2025, filed 17 Feb 2026.